Abciximab

From WikiMD.org
Jump to navigation Jump to search

Abciximab

Abciximab (pronounced as ab-siks-i-mab) is a monoclonal antibody that is primarily used in the medical field to prevent platelets in the blood from clumping together. It is often used during certain procedures used to treat heart disease.

Etymology

The name "Abciximab" is derived from the scientific nomenclature of antibodies. The "ab" stands for antibody, "ci" is indicative of its chimeric nature, "xi" denotes its binding activity, and "mab" is short for monoclonal antibody.

Usage

Abciximab is used in combination with heparin and aspirin in patients undergoing angioplasty to prevent clotting and reduce the risk of heart attack. It works by preventing platelets in the blood from sticking together and forming a clot that can block an artery or a graft.

Related Terms

  • Monoclonal Antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
  • Platelets: Small, colorless cell fragments in our blood that form clots and stop or prevent bleeding.
  • Heart Disease: A range of conditions that affect your heart. Diseases under the heart disease umbrella include blood vessel diseases, such as coronary artery disease.
  • Heparin: A medication and naturally occurring anticoagulant.
  • Aspirin: A salicylate drug, often used as an analgesic to relieve minor aches and pains, as an antipyretic to reduce fever, and as an anti-inflammatory medication.
  • Angioplasty: A minimally invasive, endovascular procedure to widen narrowed or obstructed arteries or veins.
  • Heart Attack: A blockage of blood flow to the heart muscle.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski